Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 301–400 of 1,000
Fedele, E., Varnier, G., Ansaldo, M. A., & Raiteri, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702130 · Cited by 83
“…been found to elicit release of dopamine in in vivo studies using microdialysis (Imperato et al., 1986; Pontieri et al., 1996) and this e ect in the nucleus accumbens has been linked to the dependence liability for the drug (Fibiger & Phillips, 1987; Corrigall et al., 1992; Pontieri et al., 1996).”
BackgroundTanda, G., Newman, A. H., & Katz, J. L. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57007-4 · Cited by 81
“, 1995) and other drugs abused by humans (Pontieri et al., 1996; Tanda et al., 2008; Tanda et al., 1997a), the potentiation of the effects of cocaine on DA levels selectively in the NAc shell is in disagreement with the hypothesis that M1 antagonist effects might be responsible for attenuating the reinforcing effects…”
BackgroundInfluentialSelf-citationDi Matteo, V., Pierucci, M., & Esposito, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02337.x · Cited by 76
“…in a number of studies showing that nicotine increases in vivo DA release in both brain areas (Imperato et al. 1986; Di Chiara and Imperato 1988; Damsma et al. 1989; Brazell et al. 1990; Toth et al. 1992; Nisell et al. 1994b; Pontieri et al. 1996; Maisonneuve et al. 1997; Marshall et al. 1997).”
BackgroundYamashita, M., Marszalec, W., Yeh, J. Z., & Narahashi, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106260 · Cited by 82
“Whereas the importance of the GABAA receptors in the behavioral effects of ethanol is well documented (Pontieri et al., 1996; Koob et al., 1998), the ethanol modulation of GABAA receptor activity in vitro has been very controversial (Sapp and Yeh, 1998; Aguayo et al., 2002).”
BackgroundCarboni, E., Silvagni, A., Vacca, C., & Di Chiara, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03556.x · Cited by 78
Self-citationLouis, M. S., & Clarke, P. B. S. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00151-8 · Cited by 84
Cadoni, C., Valentini, V., & Di Chiara, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05503.x · Cited by 75
Self-citationAbreu‐Villaça, Y., Queiroz-Gomes, F. D. E., Monte, A. P. D., Filgueiras, C. C., & Manhães, A. C. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.09.003 · Cited by 86
Yang, K., Hu, J., Lucero, L., Liu, Q., Zheng, C., Zhen, X., Jin, G., Lukas, R. J., & Wu, J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.162743 · Cited by 73
“Although mechanisms involved in drug dependence are not fully defined, the mesocorticolimbic dopaminergic (DAergic) system, and the ventral tegmental area (VTA) in particular, appear to play major roles (Nisell et al. 1994; Pontieri et al. 1996; Spanagel & Weiss, 1999; Dani & De Biasi, 2001; Dani et al. 2001).”
BackgroundConditioned appetitive stimulus increases extracellular dopamine in the nucleus accumbens of the rat
Datla, K. P., Ahier, R. G., Young, A. M. J., Gray, J. A., & Joseph, M. H. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02249.x · Cited by 77
“Similarly, the administration of drugs of addictive potential is also accompanied by increased DA release in nAc (Di Chiara & Imperato, 1988; Hernandez & Hoebel, 1988; Clarke, 1990; Pontieri et al., 1996).”
BackgroundDopamine Circuit Mechanisms of Addiction-Like Behaviors
Poisson, C. L., Engel, L., & Saunders, B. T. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.752420 · Cited by 75
Drug addiction: from bench to bedside
Cheron, J., & Kerchove d’Exaerde, A. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01542-0 · Cited by 75
De Luca, M. A., Castelli, M. P., Loi, B., Porcu, A., Martorelli, M., Miliano, C., Kellett, K., Davidson, C., Stair, J. L., Schifano, F., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.017 · Cited by 73
Self-citationBiological basis of tobacco addiction: Implications for smoking-cessation treatment
Jiloha, R. C. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.74303 · Cited by 88
Sorge, R. E., & Clarke, P. B. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154641 · Cited by 85
“Thus, acute subcutaneous and intravenous nicotine administration increases DA overflow in nucleus accumbens (Benwell and Balfour, 1992; Pontieri et al., 1996), and intravenous nicotine self-administration is inhibited by systemic DA antagonists (Corrigall and Coen, 1991), and by DA-depleting lesions (Corrigall et al.”
BackgroundVarenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial
Stein, M. D., Caviness, C. M., Kurth, M. E., Audet, D., Olson, J., & Anderson, B. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.005 · Cited by 75
“Overlapping neurobiological pathways in persons with dual opioid and nicotine dependence may affect withdrawal sensitivities and craving (Frosch et al., 2000; Pontieri et al., 1996).”
BackgroundChu, M., Guo, J., & Chen, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408947200 · Cited by 86
Scherma, M., Justinová, Z., Zanettini, C., Panlilio, L. V., Mascia, P., Fadda, P., Fratta, W., Makriyannis, A., Vadivel, S. K., Gamaleddin, I., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01467.x · Cited by 77
“accumbens shell is an effect considered central for the reinforcing effects of many abused drugs, including nicotine (Pontieri et al., 1996), we evaluated the effects of AM404 on nicotine-induced increases in extracellular dopamine levels in the shell of the nucleus accumbens.”
BackgroundA Role for Sigma Receptors in Stimulant Self Administration and Addiction
Katz, J. L., Su, T., Hiranita, T., Hayashi, T., Tanda, G., Kopajtic, T. A., & Tsai, S. (2011) · Pharmaceuticals · doi:10.3390/ph4060880 · Cited by 77
“NAC shell [56], a brain area related to the reinforcing effects of drugs [71-73].”
BackgroundSelf-citationPersistent dysfunctional frontal lobe activation in former smokers
Neuhaus, A. H., Bajbouj, M., Kienast, T., Kalus, P., von Haebler, D., Winterer, G., & Gallinat, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0366-7 · Cited by 81
“Like other addictive drugs, nicotine is thought to mediate its reinforcing properties by the release of dopamine from ventral tegmental area projections towards the nucleus accumbens (Mansvelder et al. 2003; Pontieri et al. 1996).”
Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens
Zernig, G., O'Laughlin, I. A., & Fibiger, H. C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01184-9 · Cited by 75
Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors
Zhang, H., & Sulzer, D. (2011) · Basal Ganglia · doi:10.1016/j.baga.2011.11.004 · Cited by 82
“Nicotine shifts VTA neurons from tonic to burst firing modes [5, 144] and enhances extracellular dopamine as measured by microdialysis [101].”
BackgroundImpulsive-compulsive behaviors in parkin -associated Parkinson disease
Morgante, F., Fasano, A. A., Ginevrino, M., Petrucci, S., Ricciardi, L., Bove, F., Criscuolo, C., Moccia, M., Rosa, A. D., Sorbera, C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003177 · Cited by 77
Kulak, J. M., McIntosh, J. M., Yoshikami, D., & Olivera, B. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00357.x · Cited by 74
Evaluating the Evidence on Sitting, Smoking, and Health: Is Sitting Really the New Smoking?
Vallance, J. K., Gardiner, P. A., Lynch, B. M., D’Silva, A., Boyle, T., Taylor, L., Johnson, S. T., Buman, M. P., & Owen, N. G. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304649 · Cited by 82
Ma, J. Z., Beuten, J., Payne, T. J., Dupont, R. T., Elston, R. C., & Li, M. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi177 · Cited by 75
“In laboratory animals, nicotine increases the release of dopamine and enhances energy metabolism via stimulation of the basal ganglia, especially in the ventral tegmental area and nucleus accumbens, similar to the effects of other addictive drugs such as cocaine, amphetamines and morphine (13,14).”
BackgroundSex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors
Harrod, S. B., Mactutus, C. F., Bennett, K., Hasselrot, U., Wu, G., Welch, M. A., & Booze, R. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.026 · Cited by 78
Yeom, M., Shim, I., Lee, H., & Hahm, D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.034 · Cited by 73
Smoking cessation 1 year poststroke and damage to the insular cortex
Suñer-Soler, R., Grau, A., Gras, M. E., Font-Mayolas, S., Silva, Y., Dávalos, A., Cruz, V., Rodrigo, J., & Serena, J. (2012) · Stroke · doi:10.1161/strokeaha.111.630004 · Cited by 71
Tranylcypromine enhancement of nicotine self-administration
Villégier, A., Lotfipour, S., McQuown, S. C., Belluzzi, J. D., & Leslie, F. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.001 · Cited by 71
Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects
Sun, W., Quizon, P. M., & Zhu, J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.017 · Cited by 77
Mündel, T. (2017) · Sports Medicine · doi:10.1007/s40279-017-0764-5 · Cited by 71
Effects of phytochemicals on cellular signaling: reviewing their recent usage approaches
Pham, D., Shibu, M. A., Mahalakshmi, B., & Velmurugan, B. K. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1699014 · Cited by 80
Cohen, A., & George, O. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00041 · Cited by 78
Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress
Lan, X., Lederman, R., Eng, J. M., Shoshtari, S. S. M., Saleem, M. A., Malhotra, A., & Singhal, P. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167071 · Cited by 70
de Haan, L., Lavalaye, J., van Bruggen, M., van Nimwegen, L., Booij, J., van Amelsvoort, T., & Linszen, D. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900503 · Cited by 68
“Nicotine stimulates the release of dopamine and the energy metabolism in the basal ganglia, especially in the ventral tegmental areas and the nucleus accumbens (28), putamen, and nucleus caudatus (29); this is probably the central reinforcing mechanism of addictive substances (30).”
Cigarette smoking and depressive symptoms: A longitudinal study of adolescents and young adults
Brook, J. S., Schuster, E., & Zhang, C. (2004) · Psychological Reports · doi:10.2466/pr0.95.1.159-166 · Cited by 68
Association of COMT Val108/158Met genotype with smoking cessation
Munafò, M. R., Johnstone, E. C., Guo, B., Murphy, M. F. G., & Aveyard, P. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f44daa · Cited by 68
Cacciapaglia, F., Saddoris, M. P., Wightman, R. M., & Carelli, R. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.027 · Cited by 77
“In fact, addictive drugs and natural rewards share the ability of preferentially increasing extracellular dopamine within the NAc shell (Pontieri et al., 1995, 1996; Tanda et al., 1997; Bassareo and Di Chiara, 1999; Aragona et al., 2008).”
Cumming, P. D., Rosa‐Neto, P., Watanabe, H., Smith, D. F., Bender, D., Clarke, P. B. S., & GJEDDE, A. H. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00079-x · Cited by 70
Panlilio, L. V., Justinová, Z., Mascia, P., Pistis, M., Luchicchi, A., Lecca, S., Barnes, C., Redhi, G. H., Adair, J. E., Heishman, S. J., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.31 · Cited by 73
“Nicotine produces rewarding effects through mesolimbic dopamine circuitry that is shared by other addictive drugs (Pontieri et al, 1996) and is concordant in humans and animals (Brody, 2006).”
Bassareo, V., De Luca, M. A., Aresu, M., Aste, A., Ariu, T., & Di Chiara, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02556.x · Cited by 66
Self-citationGuillem, K., Vouillac‐Mendoza, C., Azar, M. R., Parsons, L. H., Koob, G. F., Cador, M., & Stinus, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05217.x · Cited by 74
“motivating tobacco smoking and maintenance of tobacco addiction (Jaffe & Kanzler, 1979; Stolerman & Jarvis, 1995; Pontieri et al., 1996).”
BackgroundFrom smoking to lung cancer: the CHRNA5/A3/B4 connection
Improgo, M. R., Scofield, M. D., Tapper, A. R., & Gardner, P. D. (2010) · Oncogene · doi:10.1038/onc.2010.256 · Cited by 74
“Dopaminergic neurons in this pathway originate in the ventral tegmental area and project to the nucleus accumbens (NAc) and the prefrontal cortex.”
BackgroundInfluentialThe role of the cannabinoid system in nicotine addiction
Castañé, A., Berrendero, F., & Maldonado, R. J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.025 · Cited by 67
Foll, B. L., Ciano, P. D., Panlilio, L. V., Goldberg, S. R., & Ciccocioppo, R. (2013) · Current Drug Targets · doi:10.2174/1389450111314070006 · Cited by 70
“The involvement of dopamine in the rewarding effects of drugs of abuse is suggested by findings that most drugs abused by humans increase extracellular levels of dopamine in the nucleus accumbens (NAcc) (8, 9) and that blockade of dopamine transmission reduces the rewarding effects of psychostimulants (10).”
BackgroundHistorical and current perspective on tobacco use and nicotine addiction
Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 81
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Barson, J. R., & LEIBOWITZ, S. F. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.06.006 · Cited by 71
Nagai, T., Ito, M., Nakamichi, N., Mizoguchi, H., Kamei, H., Fukakusa, A., Nabeshima, T., Takuma, K., & Yamada, K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3139-06.2006 · Cited by 69
“Nicotine, like other drugs of abuse, activates the mesolimbic dopaminergic system and increases extracellular dopamine levels in the NAc (Pontieri et al., 1996), a feature related to its rewarding properties.”
BackgroundThe effect of nicotine on developing brain catecholamine systems
Oliff, H. (1999) · Frontiers in Bioscience · doi:10.2741/oliff · Cited by 58
“Nicotine can significantly stimulate brain DA release in the mesolimbic system (67-70), the nigrostriatal”
BackgroundAlderson, H. L., Parkinson, J. A., Robbins, T. W., & Everitt, B. J. (2000) · Psychopharmacology · doi:10.1007/s002130000634 · Cited by 79
“Heroin, cocaine, nicotine and amphetamine administration selectively increase DA levels within the shell of NAcc (Pontieri et al. 1995; Pontieri et al. 1996; Nisell et al. 1997; Hedou et al. 1999), while heroin and nicotine administration increase glucose utilisation within the shell (Orzi et al. 1996).”
BackgroundJohnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. F. G., Walton, R. T., & Munafò, M. R. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0936 · Cited by 66
“Nicotine is the main addictive component of tobacco smoking and stimulates the release of dopamine in the nucleus accumbens, which is partly responsible for its reinforcing effects (17, 18).”
BackgroundTreating Tobacco Dependence in a Medical Setting
Hurt, R. D., Ebbert, J. O., Hays, J. T., & McFadden, D. D. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20031 · Cited by 71
Quaak, M., van Schayck, C. P., Knaapen, A. M., & van Schooten, F. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00056908 · Cited by 65
Genetic influences on smoking: candidate genes.
Rossing, M. A. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106231 · Cited by 65
Anhedonia in obsessive-compulsive disorder: Beyond comorbid depression
Abramovitch, A., Pizzagalli, D. A., Reuman, L., & Wilhelm, S. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.02.002 · Cited by 64
“Additionally, nicotine potentiates activity in the NAc (Pontieri et al., 1996).”
InfluentialNicotine-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells
Kim, C. S., Choi, J. S., Joo, S. Y., Bae, E. H., Kwon, S., Lee, J., & Kim, S. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152591 · Cited by 64
“Nicotine is a major component of cigarette smoke, and is, to a large extent, responsible for the addictive effects of cigarette smoking [9].”
BackgroundSmoking and Anxiety in Combat Veterans with Chronic Posttraumatic Stress Disorder: A Review
Beckham, J. C. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471731 · Cited by 64
Shim, I., Kim, H.-T., Kim, Y., Chun, B., Hahm, D., Lee, E. H., Kim, S. E., & Lee, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01582-0 · Cited by 64
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 67
“Nicotine stimulates dopamine release in the mesolimbic pathway (Corrigall et al. 1992) by way of nAChRs located in the VTA (Nisell et al. 1994, 1995) and the nucleus accumbens (Pontieri et al. 1996).”
BackgroundCATTANEO, G. M., D'ATRI, F., & VICENTINI, M. L. (1997) · Biochemical Journal · doi:10.1042/bj3280499 · Cited by 64
Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung) des Erwachsenenalters
Krause, K., Krause, J., & Trott, G.-E. (1998) · Der Nervenarzt · doi:10.1007/s001150050311 · Cited by 91
Foll, B. L., Guranda, M., Wilson, A. A., Houle, S., Rusjan, P., Wing, V. C., Zawertailo, L. A., Busto, U. E., Selby, P. L., Brody, A. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.209 · Cited by 65
“Unlike those psychostimulants, nicotine is known to produce relatively weak elevation in DA levels (Forget et al, 2010; Pontieri et al, 1996), which may explain why initial PET studies in animals report small, inconsistent changes in response to intravenous nicotine (Cumming et al, 2003; Marenco et…”
BackgroundNicotine addiction: insights from recent animal studies
Mathieu-Kia, A.-M., Kellogg, S. H., Butelman, E. R., & Kreek, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1096-0 · Cited by 68
Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA
Houdi, A. A., Dasgupta, R., & Kindy, M. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00454-5 · Cited by 68
Dopamine efflux in nucleus accumbens shell and core in response to appetitive classical conditioning
Cheng, J. J., De Bruin, J. P. C., & Feenstra, M. G. P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02849.x · Cited by 63
Schreckenberger, M., Amberg, R., Scheurich, A., Lochmann, M., Tichy, W., Klega, A., Siessmeier, T., Gründer, G., Buchholz, H., Landvogt, C., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300453 · Cited by 66
“Stimulation of these receptors leads to inhibition of both tonic and phasic release of GABA, which is secondary followed by disinhibition of dopaminergic VTA neurons (Gysling and Wang, 1983; Dilts and Kalivas, 1989; Pontieri et al, 1996).”
BackgroundDecreased Presynaptic Sensitivity to Adenosine after Cocaine Withdrawal
Manzoni, O. J., Pujalte, D., Williams, J. T., & Bockaert, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07996.1998 · Cited by 67
“The nucleus accumbens (NAc) is a site mediating the rewarding properties of drugs of abuse, such as cocaine, amphetamine, opiates, nicotine, and alcohol (Wise and Bozarth, 1987; Koob, 1992; Samson and Harris, 1992; Woolverton and Johnson, 1992; Self and Nestler, 1995; Pontieri et al., 1996 ).”
BackgroundAssociation of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia
Novak, G., LeBlanc, M., Zai, C. C. H., Shaikh, S. A., Renou, J., Luca, V. D., Bulgin, N., Kennedy, J. L., & Foll, B. L. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00578.x · Cited by 66
“The reinforcing/rewarding effects of nicotine are mediated by the release of dopamine (DA) within the nucleus accumbens (Corrigall et al., 1992; Pontieri et al., 1996).”
BackgroundNicotine-Induced Dopamine Release in Primates Measured with [11C]Raclopride PET
Marenco, S., Carson, R. E., Berman, K. F., Herscovitch, P., & Weinberger, D. R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300287 · Cited by 66
“DA is released in the striatum of animals who receive nicotine infusions (Di Chiara, 2000; Di Chiara and Imperato, 1988; Pontieri et al, 1996).”
BackgroundResultInfluentialAge dependent nicotinic influences over dopamine neuron synaptic plasticity
Placzek, A. N., Zhang, T. A., & Dani, J. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.014 · Cited by 61
“Contents lists available at ScienceDirect Biochemical Pharmacology journa l homepage: www.e lsev ier .com/ locate /b iochempharm Abbreviations: AMPA, a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; aBTX, a-bungarotoxin; ACh, acetylcholine; ADHD, attention-deficit hyperactivity disorder; DHbE, dihydro-b-erythroidin…”
BackgroundInfluentialAddiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Virdee, K., Cumming, P. D., Caprioli, D., Jupp, B., Rominger, A., Aigbirhio, F. I., Fryer, T. D., Riss, P. J., & Dalley, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.009 · Cited by 64
Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization
Kiuchi, K., Matsuoka, M., Wu, J., Silva, R. L. E., Kengatharan, M., Mary, V., Ueno, S., Yokoi, K., Khu, N. H., Cooke, J. P., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0089 · Cited by 60
“Neuronal nAChRs mediate the stimulatory and addictive effects of nicotine.(7) Recently, it has been shown that nAChRs are expressed by vascular endothelial cells(8) and that endothelial cells synthesize, store, and release acetylcholine.”
BackgroundPharmacotherapy of smoking cessation
Jiloha, R. C. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124726 · Cited by 70
“[8] CUES TO SMOKING Some people smoke when they work alone and others when they are in company.”
Caffeine potentiates the discriminative-stimulus effects of nicotine in rats
Ga̧sior, M., Jaszyna, M., Munzar, P., Witkin, J. M., & Goldberg, S. R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1113-3 · Cited by 60
NEUROBIOLOGY OF TOBACCO SMOKING AND OTHER ADDICTIVE DISORDERS
Gamberino, W. C., & Gold, M. S. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70078-2 · Cited by 67
Monoamine oxidase polymorphisms and smoking behaviour in Japanese
Ito, H., Hamajima, N., Matsuo, K., Okuma, K., Sato, S., Ueda, R., & Tajima, K. (2003) · Pharmacogenetics · doi:10.1097/00008571-200302000-00003 · Cited by 64
Study of the behavioural responses related to the potential addictive properties of MDMA in mice
Robledo, P., Balerio, G. N., Berrendero, F., & Maldonado, R. J. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0862-9 · Cited by 64
“Increased activity in the mesolimbic dopaminergic system is thought to be a common neuronal substrate mediating the rewarding properties of prototypical drugs of abuse including alcohol, psychostimulants, nicotine, opioids, and cannabinoids (Chen et al. 1990; Yoshimoto et al. 1992; Pontieri et al. 1996; Koob and Le Mo…”
Desai, R. I., Barber, D. J., & Terry, P. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1426-x · Cited by 62
Ivanova, S. А., & Greenshaw, A. J. (1997) · Psychopharmacology · doi:10.1007/s002130050441 · Cited by 60
“Recent studies, using 2-deoxyglucose autoradiography and brain microdialysis, have demonstrated that these rewarding, or reward-enhancing actions of nicotine may be mediated by changes in dopamine transmission in the shell sub-region of the nucleus accumbens ( Pontieri et al. 1996 ).”
BackgroundInfluentialKelley, B. M., & Rowan, J. D. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.04.002 · Cited by 59
“…in vivo microdialysis studies have demonstrated that many abused drugs (i.e., cocaine, amphetamine, morphine and PCP) preferentially increase extracellular dopamine levels in the shell region versus the core region of the nucleus accumbens during IV self-administration (Pontieri et al., 1996).”
BackgroundWang, X., Jia, W.-B., Xu, X. M., Chen, R., Wang, L., Su, X.-J., Xu, P., Liu, X., Wen, J., Song, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40860-3 · Cited by 70
Role of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. H. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 58
Rahman, S., Zhang, J., & Corrigall, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00723-7 · Cited by 61
Saha, S., Scott, J. G., Varghese, D., Degenhardt, L. J., Slade, T. N., & McGrath, J. J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-202 · Cited by 59
“It is also feasible that nicotine in cigarettes could modulate mesolimbic dopamine neurotransmitter systems [35,36], which may increase the vulnerability to DLE in susceptible individuals.”
BackgroundCigarette-by-cigarette satisfaction during ad libitum smoking.
Shiffman, S., & Kirchner, T. R. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0015620 · Cited by 57
Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin
Trigo, J. M., Zimmer, A., & Maldonado, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.013 · Cited by 56
“Nicotine rewarding properties are related to its ability to increase dopamine in the mesolimbic system (Risinger and Oakes, 1995; Picciotto et al., 1998; Castañé et al., 2002), similarly to other drugs of abuse (Pontieri et al., 1996; Picciotto et al., 1998).”
BackgroundWeiss, S., Nosten‐Bertrand, M., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301385 · Cited by 61
“Nicotine, as all drugs of abuse, induces dopamine (DA) release in the shell of the nucleus accumbens (Pontieri et al, 1996; for a review, see Di Chiara et al, 2004).”
Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice
Celik, E., Uzbay, T. I., & Karakaş, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.014 · Cited by 62
Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese.
Yoshida, K., Hamajima, N., Ki, K., Saito, H., Maeno, K., Sugiura, T., Okuma, K., & Takahashi, T. (2001) · PubMed · Cited by 61
Receptor systems participating in nicotine-specific effects
Sziráki, I., Sershen, H. W., Benuck, M., Hashim, A., & Lajtha, Á. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00049-7 · Cited by 60
NON-NICOTINE PHARMACOTHERAPY FOR SMOKING CESSATION
Ferry, L. H. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70122-6 · Cited by 57
Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
Marubio, L. M., & Changeux, J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00007-8 · Cited by 61
“Nicotine, administered systemically, acts by binding to nicotinic acetylcholine receptors on either the cell soma in the substantia nigra and ventral tegmental area andror nerve terminals in . the dorsal and ventral nucleus accumbens striatum Grady . et al., 1992 , therefore activating these cells and causing an incre…”
BackgroundDawson, P., Opacka‐Juffry, J., Moffatt, J. D., Daniju, Y., Dutta, N., Ramsey, J., & Davidson, C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.013 · Cited by 59
“Typically it is found that stimulants have a greater effect on dopamine efflux in the accumbens shell versus the core (Pontieri et al., 1996), thus our results are relatively modest.”
Bassareo, V., Cucca, F., Frau, R., & Chiara, G. D. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00071 · Cited by 60
“…cocaine, amphetamine, morphine, heroin, THC, MDMA and nicotine preferentially activate shell DA transmission following response non-contingent (passive) as well as response-contingent exposure (Pontieri et al., 1995, 1996; Tanda et al., 1997; Lecca et al., 2006a,b, 2007a,b; Aragona et al., 2008).”
BackgroundSelf-citationAbnormal frontostriatal tracts in young male tobacco smokers
Yuan, K., Yu, D., Zhao, M., Li, M., Wang, R., Li, Y., Manza, P., Kojori, E. S., Wiers, C. E., Wang, G., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.08.046 · Cited by 57
“Intravenous nicotine administration in rats induced dopamine release and stimulated energy metabolism in NAc (Pontieri et al., 1996), which has a central role in the reinforcing effects of addictive compounds.”
Caffeine and accumbens shell dopamine
De Luca, M. A., Bassareo, V., Bauer, A., & Di Chiara, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04754.x · Cited by 57
“…of adenosine receptors from addictive drugs like cocaine, heroin, nicotine, and cannabinoids, that stimulate DA release in the NAc shell (Pontieri et al. 1995, 1996; Tanda et al. 1997; Di Chiara 2002) and were consistent with the failure of caffeine to be self-administered Received…”
Self-citationCocaine-Like Neurochemical Effects of Antihistaminic Medications
Tanda, G., Kopajtic, T. A., & Katz, J. L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05361.x · Cited by 56
Self-citationNeuroreceptors and Ion Channels as Targets of Alcohol
Narahashi, T., Kuriyama, K., Illés, P., Wirkner, K., Fischer, W., hlberg, K. M., Scheibler, P., Allgaier, C., Minami, K., Lovinger, D. M., et al. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00030 · Cited by 66
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.